2-(2,4-Dioxopyrimidin-1-yl)-N-(2,2,2-trifluoroethyl)acetamide, 98%, 500mg

2-(4-Aminophenoxy)acetic acid, 95.0%, 250mg

1-(2-BROMO-5-METHYLPHENYL)ETHANONE, 95.0%, 250mg

Methyl 2,6-difluoro-3-hydroxybenzoate, 95.0%, 250mg

(R)-4-(Hydroxymethyl)-1-((R)-1-phenylethyl)pyrrolidin-2-one, 95.0%, 100mg

5-(Aminomethyl)-5-(4-fluorophenyl)imidazolidine-2,4-dione hydrochloride, 95%, 100mg

Potassium Hexafluorotitanate(IV)25g

tert-butyl 4-amino-1,4'-bipiperidine-1'-carboxylate, 95.0%, 5g

(S)-2-Acetamido-3-mercaptopropanoic acid, 96.0%, 250mg

Filtration unit Stericup® with Durapore® (PVDF) membrane Pore size 0.22 μm, 150 ml, 150 ml, 12 Piece(s)

N-(tert-Butoxycarbonyl)-L-tert-leucine>98.0%(HPLC)(T)25g

1-(3-Chloro-4-fluorophenyl)-2-thiourea, 98%, 250mg

2-Amino-5-iodophenol, 95+%, 100mg